Molecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells

Anti-Cancer Drugs

Volumn 24, Issue 5, 2013, Pages 504-518

  Mezencev, Roman ^a   Wang, Lijuan ^a   Xu, Wenwei ^b   Kim, Byungkyu ^b   Sulchek, Todd A ^a,b   Daneker, George W ^c   McDonald, John F ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c CANCER TREATMENT CENTERS OF AMERICA   (United States)

Author keywords

atomic force microscopy; cancer invasion; cell stiffness; MYC; N acetyl L cysteine; nuclear factor B; pancreatic cancer; resazurin

Indexed keywords

ACETYLCYSTEINE; DOXORUBICIN; GEMCITABINE; MITOMYCIN; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL AGING; CELL ASSAY; CELL INVASION; CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; EPITHELIAL MESENCHYMAL TRANSITION; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; MITOMYCIN; PANCREATIC NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 84875850949     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32836009d7     Document Type: Article

References (82)

1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. SEER Cancer Statistics Review, National Cancer Institute, 1975-2009.
2. Bethesda, MD: Vintage 2011; Based on November 2011 SEER data submission, posted to the SEER website, 2012. Available at: http://seer.cancer.gov/csr/1975- 2009-pops09/[Accessed September 2012].
3. Li J, Wientjes MG, Au JL. Pancreatic cancer: pathobiology, treatment options, and drug delivery. AAPS J 2010; 12:223-232.
4. Supabphol A, Muangman V, Chavasiri W, Supabphol R, Gritsanapan W. N-Acetylcysteine inhibits proliferation, adhesion, migration and invasion of human bladder cancer cells. J Med Assoc Thai 2009; 92:1171-1177.
5. Vanisree AJ, Shyamaladevi CS. The effect of N-acetylcysteine in combination with vitamin C on the activity of ornithine decarboxylase of lung carcinoma cells - in vitro. Life Sci 2006; 79:654-659. (Pubitemid 43927977)
6. Yan CY, Ferrari G, Greene LA. N-acetylcysteine-promoted survival of PC12 cells is glutathione-independent but transcription-dependent. J Biol Chem 1995; 270:26827-26832.
7. Li J, Tu HJ, Li J, Dai G, Dai YC,Wu Q, et al. N-acetyl cysteine inhibits human signet ring cell gastric cancer cell line (SJ-89) cell growth by inducing apoptosis and DNA synthesis arrest. Eur J Gastroenterol Hepatol 2007; 19:769-774. (Pubitemid 47266705)
8. Lee YJ, Lee DM, Lee CH, Heo SH, Won SY, Im JH, et al. Suppression of human prostate cancer PC-3 cell growth by N-acetylcysteine involves overexpression of Cyr61, toxicol. In Vitro 2011; 25:199-205.
9. Kusano C, Takao S, Noma H, Yoh H, Aikou T, Okumura H, et al. N-Acetyl cysteine inhibits cell cycle progression in pancreatic carcinoma cells. Hum Cell 2000; 13:213-220.
10. Kawakami S, Kageyama Y, Fujii Y, Kihara K, Oshima H. Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cell. Anticancer Res 2001; 21:213-219.
11. Albini A, D'Agostini F, Giunciuglio D, Paglieri I, Balansky R, De Flora S. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int J Cancer 1995; 61:121-129.
12. Agarwal A, Munoz-Ná jar U, Klueh U, Shih SC, Claffey KP. N-Acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer. Am J Pathol 2004; 164:1683-1696. (Pubitemid 38529771)
13. De Flora S, Izzotti A, D'Agostini F, Balansky RM. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 2001; 22:999-1013. (Pubitemid 32633597)
14. Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante R, Sanders WH, et al. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro 1982; 18:24-34. (Pubitemid 12116070)
15. O'Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000; 267:5421-5426.
16. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 1991; 51:2515-2520, Erratum in: Cancer Res. 51:4501.
17. Jeng YJ, Watson CS. Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases. BMC Cancer 2009; 9:334.
18. Jayaraman S. Flow cytometric determination of mitochondrial membrane potential changes during apoptosis of T lymphocytic and pancreatic bet cell lines: comparison of tetramethylrhodamineethylester (TMRE), chloromethyl- X-rosamine (H2-CMK-Ros) and MitoTracker Red 580 (MTR580). J Immunol Methods 2005; 306:68-79. (Pubitemid 41742215)
19. Reutelingsperger CP, van Heerde WL. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and 625 coagulation during apoptosis. Cell Mol Life Sci 1997; 53:527-532. (Pubitemid 27374494)
20. Mezencev R, Updegrove T, Kutschy P, Repovská M, McDonald JF. Camalexin induces apoptosis in T-leukemia Jurkat cells by increased concentration of reactive oxygen species and activation of caspase-8 and caspase-9. J Nat Med 2011; 65:488-499.
21. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92:9363-9367.
22. XuW, Mezencev R, Kim B,Wang L, McDonald JF, Sulchek TA. Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells. PLoS One 2012; 7:e46609.
23. Kundu K, Knight SF,Willett N, Lee S, Taylor WR, Murthy N. Hydrocyanines: a class of fluorescent sensors that can image reactive oxygen species in cell culture, tissue, and in vivo. Angew Chem Int Ed Engl 2009; 48:299-303.
24. Finn NA, Findley HW, Kemp ML. A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity. PLoS Comput Biol 2011; 7:e1002151.
25. Hempel SL, Buettner GR, O'Malley YQ, Wessels DA, Flaherty DM. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 20,70-dichlorodihydrofluorescein diacetate, 5(and 6)- carboxy-20,70-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 1999; 27:146-159. (Pubitemid 29353095)
26. Jakubowski W, Bartosz G. 2,7-Dichlorofluorescin oxidation and reactive oxygen species: what does it measure? Cell Biol Int 2000; 24:757-760.
27. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 2003; 278:3170-3175. (Pubitemid 36801227)
28. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436:720-724. (Pubitemid 41117276)
29. Ruiz S, Brennand K, Panopoulos AD, Herreri'as A, Gage FH, Izpisua-Belmonte JC. High-efficient generation of induced pluripotent stem cells from human astrocytes. PLoS One 2010; 5:e15526.
30. Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 2009; 138:245-256.
31. Pattyn F, Speleman F, Depaepe A, Vandesompele J. RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res 2003; 31:122-123. (Pubitemid 36150349)
32. Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF. Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Mol Cell Biochem 2012; 363:257-268.
33. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30:e36.
34. Nikolsky Y, Kirillov E, Zuev R, Rakhmatulin E, Nikolskaya T. Functional analysis of OMICs data and small molecule compounds in an integrated 'knowledge based' platform. Methods Mol Biol 2009; 563:177-196.
35. Lu W, McCallum L, Irvine AE. A rapid and sensitive method for measuring cell adhesion. J Cell Commun Signal 2009; 3:147-149.
36. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S. Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. J Neurochem 1995; 65:2585-2593.
37. Donadelli M, Costanzo C, Beghelli S, Scupoli MT, Dandrea M, Bonora A, et al. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. Biochim Biophys Acta 2007; 1773: 1095-1106. (Pubitemid 46898677)
38. Schmitt-Graff A, Scheulen ME. Prevention of adriamycin cardiotoxicity by niacin, isocitrate or N-acetyl-cysteine in mice. A morphological study. Pathol Res Pract 1986; 181:168-174. (Pubitemid 16021503)
39. Lee CS, Park SY, Ko HH, Han ES. Effect of change in cellular GSH levels on mitochondrial damage and cell viability loss due to mitomycin C in small cell lung cancer cells. Biochem Pharmacol 2004; 68:1857-1867. (Pubitemid 39278508)
40. Jardine LJ. Identification of senescence in cancer cells. In: Langdon SP, editor. Methods in molecular medicine, Vol 88: cancer cell culture: methods and protocols. Totowa, NJ: Humana Press Inc.; 2004. pp. 231-238.
41. Swaminathan V, Mythreye K, O'Brien ET, Berchuck A, Blobe GC, Superfine R. Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. Cancer Res 2011; 71:5075-5080.
42. Qanungo S,Wang M, Nieminen AL. N-Acetyl-L-cysteine enhances apoptosis through inhibition of nuclear factor-kappaB in hypoxic murine embryonic fibroblasts. J Biol Chem 2004; 279:50455-50464.
43. Pajonk F, Riess K, Sommer A, McBride WH. N-Acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-kappaB activation. Free Radic Biol Med 2002; 32:536-543. (Pubitemid 34215038)
44. Schubert SY, Neeman I, Resnick N. A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J 2002; 16:1931-1933.
45. Li YQ, Zhang ZX, Xu YJ, Ni W, Chen SX, Yang Z, et al. N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms. Acta Pharmacol Sin 2006; 27:339-346. (Pubitemid 43357031)
46. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, Shelton MD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 2008; 10:1941-1988.
47. Willis BC, Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293:L525-L534. (Pubitemid 47358808)
48. Shimojo Y, Akimoto M, Hisanaga T, Tanaka T, Tajima Y, Honma Y, et al. Attenuation of reactive oxygen species by antioxidants suppresses hypoxiainduced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells. Clin Exp Metastasis 2013; 30:143-154.
49. Strimpakos AS, Syrigos KN, Saif MW. Novel agents in early phase clinical studies on refractory pancreatic cancer. JOP 2012; 13:166-168.
50. Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 2004; 18:703-710. (Pubitemid 38900879)
51. Ithana K, Campisi J, Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated b-galactosidase assay. In: Tollefsbol TO, editor. Methods in molecular biology: biological aging: methods and protocols. Totowa, NJ: Humana Press 2007. pp. 21-31. (Pubitemid 350183415)
52. Kong Y, Cui H, Ramkumar C, Zhang H. Regulation of senescence in cancer and aging. J Aging Res 2011; 2011:963172.
53. Tsugu A, Sakai K, Dirks PB, Jung S,Weksberg R, Fei YL, et al. Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence. Am J Pathol 2000; 157:919-932. (Pubitemid 32109384)
54. Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 1995; 92:4337-4341.
55. Wu CH, van Riggelen J, Yetil A, Fan AC, Bachireddy P, Felsher DW. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci USA 2007; 104:13028-13033. (Pubitemid 351737587)
56. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress Bcl2 is involved. Cancer Res 1995; 55:2284-2292.
57. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999; 5:119-127. (Pubitemid 29045184)
58. Xiong HQ, Abbruzzese JL, Lin E, Wang L, Zheng L, Xie K. NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells. Int J Cancer 2004; 108:181-188. (Pubitemid 37541768)
59. Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-kB and nuclear factor-kB regulated gene products in pancreatic cancer both in vitro and in vivo. J Cancer Res Clin Oncol 2012; 138:785-797.
60. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 1999; 401:86-90.
61. Dang CV. MYC on the path to cancer. Cell 2012; 149:22-35.
62. Kleine-Kohlbercher D, Adhikary S, Eilers M. Mechanisms of transcriptional repression by Myc. In: Eisenman RN, editor. The Myc/Max/Mad transcription factor network. Berlin Heidelberg: Springer-Verlag; 2006. pp. 51-62. (Pubitemid 43268503)
63. Rottmann S, Luscher B. The Mad side of the Max network: antagonizing the function of Myc and more. In: Eisenman RN, editor. The Myc/Max/Mad transcription factor network. Berlin Heidelberg: Springer-Verlag; 2006. pp. 63-122. (Pubitemid 43268504)
64. Cho KB, Cho MK, Lee WY, Kang KW. Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells. Cancer Lett 2010; 293:230-239.
65. Felton VM, Borok Z,Willis BC. N-Acetylcysteine inhibits alveolar epithelial- mesenchymal transition. Am J Physiol Lung Cell Mol Physiol 2009; 297:L805-L812.
66. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118:277-279. (Pubitemid 39061108)
67. Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004; 1014:155-163. (Pubitemid 38594801)
68. Thompson EW, Newgreen DF. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 2005; 65:5991-5995. (Pubitemid 40994377)
69. Cowin P, Rowlands TM, Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005; 17:499-508. (Pubitemid 41267164)
70. Moen I, Øyan AM, Kalland KH, Tronstad KJ, Akslen LA, Chekenya M, et al. Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model. PLoS One 2009; 4:e6381.
71. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425:851-856. (Pubitemid 37355945)
72. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, et al. A paracrine requirement for hedgehog signaling in cancer. Nature 2008; 455:406-410.
73. Huang FT, Zhuan-Sun YX, Zhuang YY, Wei SL, Tang J, Chen WB, et al. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance. Int J Oncol 2012; 41:1707-1714.
74. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 2007; 67:2187-2196. (Pubitemid 46424238)
75. De Flora S, Balansky R, Bennicelli C, Camoirano A, D'Agostini F, Izzotti A, et al. Mechanisms of anticarcinogenesis: the example of N-acetylcysteine. In: Ioannides C, Lewis DFV, editors. Drugs, diet and disease, Vol. 1. Mechanistic approaches to cancer. Hemel Hempstead, UK: Ellis Horwood1995. pp. 151-203.
76. Menon SG, Sarsour EH, Kalen AL, Venkataraman S, Hitchler MJ, Domann FE, et al. Superoxide signaling mediates N-acetyl-L-cysteineinduced G1 arrest: regulatory role of cyclin D1 and manganese superoxide dismutase. Cancer Res 2007; 67:6392-6399. (Pubitemid 47037523)
77. Oikawa S, Yamada K, Yamashita N, Tada-Oikawa S, Kawanishi S. N-Acetylcysteine, a cancer chemopreventive agent, causes oxidative damage to cellular and isolated DNA. Carcinogenesis 1999; 20:1485-1490. (Pubitemid 29385434)
78. Kelloff GJ, Crowell JA, Boone CW, Steele VE, Lubet RA, Greenwald P, et al. Clinical development plan: N-acetyl-L-cysteine. J Cell Biochem 1994; 20 (Suppl):63-73.
79. Stey C, Steurer J, Bachmann S, Medici TC, Tramer MR. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J 2000; 16:253-262. (Pubitemid 30624944)
80. Tossios P, Bloch W, Huebner A, Raji MR, Dodos F, Klass O, et al. N-Acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2003; 126:1513-1520. (Pubitemid 37449181)
81. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989; 37:501-506. (Pubitemid 20013446)
82. Hong SY, Gil HW, Yang JO, Lee EY, Kim HK, Kim SH, et al. Effect of highdose intravenous N-acetylcysteine on the concentration of plasma sulfurcontaining amino acids. Korean J Intern Med 2005; 20:217-223.